United States · 
Who invested in Prevail Therapeutics?
Prevail Therapeutics's investors include OrbiMed, RA Capital Management, Alexandria Real Estate Equities, Omega Funds and Adage Capital Management, and 6 more on record.
United States · Series B startup
Who invested in Prevail Therapeutics
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2019, from 1 source
- Latest round
- Series B, $50MMar 2019
- Investors
- 11
The rounds
- Mar 2019
Founders and team
From the SEC filings it signed: 1 on the team.
- Asa AbeliovichExecutive Officer, Directori
On the board, as filediCarl GordonMona AshiyaPeter Thompson
Everyone who backed them
Adage Capital ManagementAsset manager1round
BVF PartnersVC firm1round
SurveyorPrivate equity1round
Pontifaxno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Prevail Therapeutics
How much has Prevail Therapeutics raised?
Prevail Therapeutics has raised $50M across 1 round since 2019.
When did Prevail Therapeutics last raise?
Prevail Therapeutics's most recent round was a Series B of $50M in Mar 2019.
What was Prevail Therapeutics's biggest round?
Its most recent round, $50M in Mar 2019, is also its largest on record.
Who backed Prevail Therapeutics first?
Prevail Therapeutics's first round on record, in Mar 2019, was backed by OrbiMed, RA Capital Management and Alexandria Real Estate Equities and 8 others.
What stage is Prevail Therapeutics at?
Prevail Therapeutics's latest named round is a Series B, in Mar 2019.
Where is Prevail Therapeutics based?
Prevail Therapeutics is based in the United States.
Companies like Prevail Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.